Skip to main navigation Skip to search Skip to main content

Implications of the 2023–2024 MPXV clade I outbreak in the Democratic Republic of Congo to global public health

  • Angel N. Desai
  • , Marion Koopmans
  • , Ashley Otter
  • , Martin P. Grobusch
  • , Pikka Jokelainen
  • , Barry Atkinson
  • , Flavia Cunha
  • , Sofia R. Valdoleiros
  • , Veronica G. Preda
  • , Francesco Maria Fusco
  • , Chantal P. Rovers
  • , Gilbert Greub
  • , Antonino Di Caro
  • , Lone Simonsen
  • , Francine Ntoumi
  • , Eskild Petersen*
  • *Corresponding author for this work
  • University of California at Davis
  • ESCMID
  • UK Health Security Agency
  • Amsterdam UMC
  • University of Tübingen
  • Statens Serum Institut
  • Centro Hospitalar Universitário de São João
  • University of Porto
  • Imperial College London
  • Azienda Ospedaliera D. Cotugno
  • Radboud University Medical Center
  • University of Lausanne
  • University Hospital Lausanne
  • IRCCS Ospedale Sacro Cuore Don Calabria
  • Saint Camillus International University of Health and Medical Sciences
  • Roskilde University
  • Fondation Congolaise pour la Recherche Médicale (FCRM)
  • Aarhus University

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

12 Citations (Scopus)
42 Downloads (Pure)
Original languageEnglish
Pages (from-to)1092-1094
Number of pages3
JournalClinical Microbiology and Infection
Volume30
Issue number9
DOIs
Publication statusPublished - Sept 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this